- Connecting Healthcare & Clinical Research
Leave No Patients Behind™ Learn More
What We Do
BlueCloud® by HealthCarePoint is a private networking technology that seamlessly connects healthcare and clinical research industry stakeholders, enabling them to create unique, private business applications that improve patient care, expedite communications, streamline standards and eliminate fraud and abuse.
The BlueCloud® universal network reaches more than 162 countries and is used by over 1,000,000 healthcare professionals including 45 Sponsors, 14 CROs, 8 IRBs, universities, sites and other healthcare and clinical research industry stakeholders. Dozens of BlueCloud applications empower users to organize, centralize, connect, share and deliver verifiable, on-demand information required for doing business as well as for compliance through a common, secure system. The BlueCloud Network is saving the industry time, money and ultimately, saving lives.
How We Give Back
The Research Literacy Connections for Tomorrow’s Cures campaign is a collaboration between the Center for Information and Study on Clinical Research Participation (CISCRP) and BlueCloud® by HealthCarePoint, for which BlueCloud® will donate one dollar per connection made on its online networking platform for CISCRP, in support of education and outreach to students and their families about clinical research. Dollar raised from the campaign will directly support the development of CISCRP’s Medical Heroes: A Traveling Museum Exhibit, which will engage elementary through high school age children and their families in 12 U.S. cities with interactive and experimental learning about the clinical research process and the role that clinical trials play in advancing public health. To learn more about CISCRP or the Medical Heroes Travel Museum, please visit www.ciscrp.org. Your BlueCloud® connections will make a difference for tomorrow’s cures!
- “When NINDS produced a full and accurate, high quality program for the NIH Stroke Scale in 2002, we knew it was something the research community badly needed. But I don’t think we could have ever dreamed that the program would reach this many people. We are impressed by the fact that this important medical tool has been made available globally, and to so many disciplines.”Walter J. Koroshetz, MDNIH